image
Fate Therapeutics, Inc. FATE
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 2.02
-2.88 %
$ 230 M
Market Cap
-1.23
P/E
BALANCE SHEET
506 M ASSETS
-28.25%
Growth Rates
1Year -28.25%
3Years -6.66%
5Years 18.90%
7Years 26.99%
10Years 24.72%
138 M LIABILITIES
-37.82%
Growth Rates
1Year -37.82%
3Years -16.65%
5Years 21.26%
7Years 30.06%
10Years 40.09%
368 M EQUITY
-23.87%
Growth Rates
1Year -23.87%
3Years -1.41%
5Years 18.08%
7Years 25.98%
10Years 21.90%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Fate Therapeutics, Inc.
image
Current Assets 332 M
Cash & Short-Term Investments 315 M
Receivables 1.83 M
Other Current Assets 14.5 M
Non-Current Assets 175 M
Long-Term Investments 980 K
PP&E 159 M
Other Non-Current Assets 15.2 M
Current Liabilities 39.1 M
Accounts Payable 4.72 M
Short-Term Debt 12.4 M
Other Current Liabilities 22 M
Non-Current Liabilities 98.7 M
Long-Term Debt 97.4 M
Other Non-Current Liabilities 1.35 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
ASSETS
Cash & Cash Equivalents 41.9 61.3 133.6 167.3 99.8 190.5 89.0 88.6 64.8 49.1 54.0 9.1 6.4
Short Term Investments 273.3 374.9 482.3 315.6 121.6 10.5 12.0 3.5 0 0 0 0 0
Receivables 1.8 38.5 8.7 5.5 0 0.5 0 0 0 0 0 0 0
Inventory 0 1 0 1 0 1 0 0 0 0 0 0 0
Other Current Assets 14.5 27.4 8.8 4.4 4.7 3.7 3.3 2.4 1.7 1.5 1.2 0.7 0.3
Total Current Assets 331.5 502.1 633.4 494.3 227.1 205.2 102.6 93.3 65.7 49.9 54.7 9.8 6.7
PP&E 158.5 66.1 70.7 67.1 22.8 5.1 2.5 1.6 2.2 1.2 0.8 1.2 1.0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 1.0 4.9 100.7 28.7 39.4 2.2 0.1 0.1 0.1 0 0 0 0
Other Long Term Assets 15.2 132.5 116.7 32.3 13.0 0.5 24 K 24 K 24 K 0.1 0.1 0.1 0.1
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 506.2 705.6 921.5 622.5 302.3 213.0 105.3 95.0 68.0 51.2 55.6 11.1 7.9
LIABILITIES
Accounts Payable 4.7 8.3 8.6 6.3 5.8 4.2 1.7 0.9 1.0 0.6 0.7 1.2 1.9
Short Term Debt 12.4 11.3 11.2 6.7 3.4 2.4 0 8.2 6.6 1.5 1.7 1.9 1.2
Other Current Liabilities 21.3 52.3 40.0 51.4 15.8 13.0 7.3 4.0 2.5 2.4 2.2 1.4 0.2
Total Current Liabilities 39.1 114.1 81.3 85.6 27.8 27.3 11.0 15.2 13.4 4.6 4.6 4.8 3.7
Long Term Debt 97.4 103.7 109.2 93.9 25.2 12.4 14.8 2.5 10.7 18.1 0 1.7 3.6
Deferred Tax Income 0 0 24.2 11.7 0 0 0 0 0 0 0 0 0
Other Liabilities 1.3 3.9 25.0 12.5 0.7 5.4 1.5 1.4 0.9 0.2 0.1 57.3 51.3
Total Liabilities 137.8 221.6 242.6 238.0 57.5 52.6 28.1 21.9 29.9 22.9 4.7 63.9 58.5
EQUITY
Common Stock 99 K 97 K 96 K 88 K 76 K 65 K 53 K 41 K 29 K 21 K 20 K 1 K 1 K
Retained Earnings (1 211.7) (1 050.8) (769.1) (556.9) (383.5) (285.4) (218.8) (175.8) (142.4) (112.4) (86.5) (65.6) (51.4)
Other Accumulative Comprehensive Income/Loss 15 K (1.9) (0.8) 70 K 22 K 2 K 3 K 1 K (3.5) (2.8) (2.3) (1.7) (1.2)
Total Equity 368.4 483.9 678.8 384.4 244.8 160.5 77.2 73.2 38.0 28.3 50.8 (52.8) (50.7)
Total Liabilities and Equity 506.2 705.6 921.5 622.5 302.3 213.0 105.3 95.0 68.0 51.2 55.6 11.1 7.9
SHARES OUTSTANDING
Common Shares Outstanding 98.4 96.8 94.7 82.4 68.2 56.2 42.0 31.8 25.5 20.5 5.9 8.9 8.9